2-hydroxy-5-(2-((2-hydroxy-3-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)phenoxy)propyl)amino)ethoxy)benzamide

Catalog No. :
ACTKBQ371
CAS No. :
137888-49-4
Molecular Formula :
C23H25F3N4O5
Molecular Weight :
494.47

IUPAC Name:2-hydroxy-5-(2-((2-hydroxy-3-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)phenoxy)propyl)amino)ethoxy)benzamide

2-hydroxy-5-(2-((2-hydroxy-3-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)phenoxy)propyl)amino)ethoxy)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-hydroxy-5-(2-((2-hydroxy-3-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)phenoxy)propyl)amino)ethoxy)benzamide
IUPAC Name2-hydroxy-5-(2-((2-hydroxy-3-(4-(1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl)phenoxy)propyl)amino)ethoxy)benzamide
Molecular FormulaC23H25F3N4O5
Molecular Weight494.47
SMILESCN1C=C(C(F)(F)F)N=C1C1=CC=C(OCC(O)CNCCOC2=CC(C(N)=O)=C(O)C=C2)C=C1
InChI KeyGKJZEKSHCJELPL-UHFFFAOYSA-N
SynonymSDCCGSBI-0050352.P002 | (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1h-imidazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamide | NCGC00024944-04 | NCGC00024944-08 | UNII-SIO2UEZ19H | Lopac0_000364 | CGP20712A | CGP-20712A | PDSP1_0008
CAS No.137888-49-4
PubChem CID2685

Synthetic Route by SureRoute

1. ACTKBQ371 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTKBQ371 route product structure diagram
    ACTKBQ371137888-49-4
Inquiry

2. ACTKBQ371 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTKBQ371 route product structure diagram
    ACTKBQ371137888-49-4
Inquiry

Comments (0)